Palivizumab
ATC J06BD01 · 9 markets · 22 records
GB 4 records · 4 strengths
- 100 mginjectionSynagis 100mg powder and solvent for solution for injection vials
- 100 mg/1 mLinjectionSynagis 50mg/0.5ml solution for injection vials
- 50 mginjectionSynagis 100mg powder and solvent for solution for injection vials
- 50 mg/0.5 mLinjectionSynagis 50mg/0.5ml solution for injection vials
AU 3 records · 3 strengths
- 100 mginjectionSYNAGIS palivizumab (rmc) 50 mg / 0.5 mL solution for injection vial
- 50 mginjectionSYNAGIS palivizumab (rmc) 50 mg / 0.5 mL solution for injection vial
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
HK 2 records · 1 strengths
2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
FR 2 records · 2 strengths
- 100 mg/1 mLinjectionSYNAGIS 100 mg/ml, solution injectable
- 50 mg/0.5 mLinjectionSYNAGIS 50 mg/0,5 ml, solution injectable
SG 1 records · 1 strengths
- 100 mg/mLinjectionSYNAGIS SOLUTION FOR INJECTION 100MG/ML
TW 1 records · 1 strengths
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
| Strength / form / release | GB | AU | SG | TW | HK | EU | FR |
|---|---|---|---|---|---|---|---|
| 100 mg injection | Synagis 100mg powder and solvent for solution for injection vials | SYNAGIS palivizumab (rmc) 50 mg / 0.5 mL solution for injection vial | |||||
| 100 mg/1 mL injection | Synagis 50mg/0.5ml solution for injection vials | SYNAGIS 100 mg/ml, solution injectable | |||||
| 50 mg injection | Synagis 100mg powder and solvent for solution for injection vials | SYNAGIS palivizumab (rmc) 50 mg / 0.5 mL solution for injection vial | |||||
| 50 mg/0.5 mL injection | Synagis 50mg/0.5ml solution for injection vials | SYNAGIS 50 mg/0,5 ml, solution injectable | |||||
| 100 mg/mL injection | SYNAGIS SOLUTION FOR INJECTION 100MG/ML | ||||||
unknown | SYNAGIS | SYNAGIS SOLUTION FOR INJECTION 100MG/1ML | SYNAGIS | ||||
injection | SYNAGIS 100mg/ml solution for 西那吉斯注射液劑100毫克/毫升 |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
2 more strength/form rows are recorded only in SG · TW and are not shown in this table. Hay 2 filas de concentración/forma registradas solo en SG · TW que no se muestran en esta tabla. 另有 2 个规格/剂型仅在 SG · TW 有记录(未在本表显示)。 另有 2 個規格/劑型僅在 SG · TW 有記錄(未在本表顯示)。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.